Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03315130
Recruitment Status : Completed
First Posted : October 19, 2017
Last Update Posted : April 1, 2021
Information provided by (Responsible Party):
Ra Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 10, 2018
Actual Study Completion Date : November 19, 2020
Certification/Extension First Submitted : August 25, 2020